{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:19:51Z","timestamp":1790428791083,"version":"4.1.0"},"reference-count":38,"publisher":"Japan Atherosclerosis Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2009]]},"DOI":"10.5551\/jat.2030","type":"journal-article","created":{"date-parts":[[2011,6,16]],"date-time":"2011-06-16T13:45:38Z","timestamp":1308231938000},"page":"807-814","source":"Crossref","is-referenced-by-count":25,"title":["Imaging of Structural Changes in Endothelial Cells and Thrombus Formation at the Site of FeCl<sub>3<\/sub>-Induced Injuries in Mice Cremasteric Arteries"],"prefix":"10.5551","volume":"16","author":[{"given":"Yota","family":"Kawamura","sequence":"first","affiliation":[{"name":"Department of Medicine (Cardiology), Center for Metabolic Disease Research, Bioresearch Center, Tokai University School of Medicine."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Takahari","sequence":"additional","affiliation":[{"name":"Teaching and Research Support Center, Tokai University School of Medicine."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Medicine (Cardiology), Center for Metabolic Disease Research, Bioresearch Center, Tokai University School of Medicine."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Eguchi","sequence":"additional","affiliation":[{"name":"Department of Physiology, Tokai University School of Medicine."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Urano","sequence":"additional","affiliation":[{"name":"Department of Medicine (Cardiology), Center for Metabolic Disease Research, Bioresearch Center, Tokai University School of Medicine."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Ishida","sequence":"additional","affiliation":[{"name":"Department of Physiology, Tokai University School of Medicine."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Goto","sequence":"additional","affiliation":[{"name":"Department of Medicine (Cardiology), Center for Metabolic Disease Research, Bioresearch Center, Tokai University School of Medicine."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Mateen FJ, Shuaib A: Progress in clinical neurosciences: The ‘antiplatelet’ agents and the role of the endothelium. Can J Neurol Sci, 2007; 34: 270-279","DOI":"10.1017\/S0317167100006685"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Bassenge E: Antiplatelet effects of endothelium-derived relaxing factor and nitric oxide donors. Eur Heart J, 1991; 12 Suppl E: 12-15","DOI":"10.1093\/eurheartj\/12.suppl_E.12"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Loscalzo J: Antiplatelet and antithrombotic effects of organic nitrates. Am J Cardiol, 1992; 70: 18B-22B","DOI":"10.1016\/0002-9149(92)90590-U"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Bouaziz A, de Ficquelmont-Loïzos MM, Richert A, Caprani A: Direct physical factors and PGI2 and TXA2 secretions by a human endothelial cell line: in vitro investigation of pressure and shear stress applied independently or in synergy. Thromb Res, 1998; 90: 279-289","DOI":"10.1016\/S0049-3848(98)00059-0"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Shatos MA, Doherty JM, Hoak JC: Alterations in human vascular endothelial cell function by oxygen free radicals. Platelet adherence and prostacyclin release. Arterioscler Thromb, 1991; 11: 594-601","DOI":"10.1161\/01.ATV.11.3.594"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Goto S: Cilostazol: potential mechanism of action for antithrombotic effects accompanied by a low rate of bleeding. Atheroscler Suppl, 2005; 6: 3-11","DOI":"10.1016\/j.atherosclerosissup.2005.09.002"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Fujii S, Sawa H, Sobel BE: Inhibition of endothelial cell expression of plasminogen activator inhibitor type-1 by gemfibrozil. Thromb Haemost, 1993; 70: 642-647","DOI":"10.1055\/s-0038-1649642"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Ruggeri ZM: Platelets in atherothrombosis. Nat Med, 2002; 8: 1227-1234","DOI":"10.1038\/nm1102-1227"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Goto S. Understanding the mechanism and prevention of arterial occlusive thrombus formation by anti-platelet agents. Curr Med Chem Cardiovasc Hematol Agents, 2004; 2: 149-156","DOI":"10.2174\/1568016043477233"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Fuster V, Lewis A: Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation, 1994; 90: 2126-2146","DOI":"10.1161\/01.CIR.90.4.2126"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Farb A, Burke AP, Tang AL, Liang TY, Mannan P, Smialek J, Virmani R: Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation, 1996; 93: 1354-1363","DOI":"10.1161\/01.CIR.93.7.1354"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Arbustini E, Dal Bello B, Morbini P, Burke AP, Bocciarelli M, Specchia G, Virmani R: Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction. Heart, 1999; 82: 269-272","DOI":"10.1136\/hrt.82.3.269"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Falati S, Patil S, Gross PL, Stapleton M, Merrill-Skoloff G, Barrett NE, Pixton KL, Weiler H, Cooley B, Newman DK, Newman PJ, Furie BC, Furie B, Gibbins JM: Platelet PECAM-1 inhibits thrombus formation in vivo. Blood, 2006; 107: 535-541","DOI":"10.1182\/blood-2005-04-1512"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Nieswandt B, Aktas B, Moers A, Sachs UJ: Platelets in atherothrombosis: lessons from mouse models. J Thromb Haemost, 2005; 3: 1725-1736","DOI":"10.1111\/j.1538-7836.2005.01488.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Falati S, Gross P, Merrill-Skoloff G, Furie BC, Furie B: Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat Med, 2002; 8: 1175-1181","DOI":"10.1038\/nm782"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Rosen ED, Gailani D, Castellino FJ: FXI is essential for thrombus formation following FeCl3-induced injury of the carotid artery in the mouse. Thromb Haemost, 2002; 87: 774-776","DOI":"10.1055\/s-0037-1613081"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Lockyer S, Kambayashi J: Demonstration of flow and platelet dependency in a ferric chloride-induced model of thrombosis. J Cardiovasc Pharmacol, 1999; 33: 718-725","DOI":"10.1097\/00005344-199905000-00007"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Berman RS, Martin W: Arterial endothelial barrier dysfunction: actions of homocysteine and the hypoxanthine-xanthine oxidase free radical generating system. Br J Pharmacol, 1993; 108: 920-926","DOI":"10.1111\/j.1476-5381.1993.tb13487.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Yamashita T, Shoge M, Oda E, Yamamoto Y, Giddings JC, Kashiwagi S, Suematsu M, Yamamoto J: The free-radical scavenger, edaravone, augments NO release from vascular cells and platelets after laser-induced, acute endothelial injury in vivo. Platelets, 2006; 17: 201-206","DOI":"10.1080\/09537100500444063"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Hoshina K, Endo Y: Laser induced fluorescence spectroscopy of the C3N radical. J Chem Phys, 2007; 127: 184304","DOI":"10.1063\/1.2783846"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Goto S, Tamura N, Ishida H, Ruggeri ZM: Dependence of platelet thrombus stability on sustained glycoprotein IIb\/IIIa activation through adenosine 5'-diphosphate receptor stimulation and cyclic calcium signaling. J Am Coll Cardiol, 2006; 47: 155-162","DOI":"10.1016\/j.jacc.2005.08.055"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Goto S, Tamura N, Handa S, Arai M, Kodama K, Takayama H: Involvement of glycoprotein VI in platelet thrombus formation on both collagen and von Willebrand factor surfaces under flow conditions. Circulation, 2002; 106: 266-272","DOI":"10.1161\/01.CIR.0000021427.87256.7E"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Goto S, Tamura N, Eto K, Ikeda Y, Handa S: Functional significance of adenosine 5'-diphosphate receptor (P2Y(12)) in platelet activation initiated by binding of von Willebrand factor to platelet GP Ibalpha induced by conditions of high shear rate. Circulation, 2002; 105: 2531-2536","DOI":"10.1161\/01.CIR.0000016703.93845.AF"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Wang X, Xu L: An optimized murine model of ferric chloride-induced arterial thrombosis for thrombosis research. Thromb Res, 2005; 115: 95-100","DOI":"10.1016\/j.thromres.2004.07.009"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Aoki T, Cox D, Senzaki K, Seki J, Tanaka A, Takasugi H, Motoyama Y: Comparison of the antithrombotic effects of FK633, GPIIb\/IIIa antagonist, and aspirin in a guinea pig thrombosis model. Thromb Res, 1998; 89: 129-136","DOI":"10.1016\/S0049-3848(97)00308-3"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Vesvres MH, Doutremepuich F, Lalanne MC, Doutremepuich C: Effects of aspirin on embolization in an arterial model of laser-induced thrombus formation. Haemostasis, 1993; 23: 8-12","DOI":"10.1159\/000216846"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Folts JD, Schafer AI, Loscalzo J, Willerson JT, Muller JE: A perspective on the potential problems with aspirin as an antithrombotic agent: a comparison of studies in an animal model with clinical trials. J Am Coll Cardiol, 1999; 33: 295-303","DOI":"10.1016\/S0735-1097(98)00601-9"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Fuster V, Moreno PR, Fayad ZA, Corti R, Badimon JJ: Atherothrombosis and high-risk plaque: part I: evolving concepts. J Am Coll Cardiol, 2005; 46: 937-954","DOI":"10.1016\/j.jacc.2005.03.074"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Ni H: Unveiling the new face of fibronectin in thrombosis and hemostasis. J Thromb Haemost, 2006; 4: 940-942","DOI":"10.1111\/j.1538-7836.2006.01899.x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Goto S, Ikeda Y, Saldivar E, Ruggeri ZM: Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions. J Clin Invest, 1998; 101: 479-486","DOI":"10.1172\/JCI973"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Goto S: Understanding the mechanism of platelet thrombus formation under blood flow conditions and the effect of new antiplatelet agents. Curr Vasc Pharmacol, 2004; 2: 23-32","DOI":"10.2174\/1570161043476456"},{"key":"32","unstructured":"32) A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet, 1996; 348: 1329-1339"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Kamae T, Shiraga M, Kashiwagi H, Kato H, Tadokoro S, Kurata Y, Tomiyama Y, Kanakura Y: Critical role of ADP interaction with P2Y12 receptor in the maintenance of alpha(IIb)beta3 activation: association with Rap1B activation. J Thromb Haemost, 2006; 4: 1379-1387","DOI":"10.1111\/j.1538-7836.2006.01941.x"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Shiraga M, Miyata S, Kato H, Kashiwagi H, Honda S, Kurata Y, Tomiyama Y, Kanakura Y: Impaired platelet function in a patient with P2Y12 deficiency caused by a mutation in the translation initiation codon. J Thromb Haemost, 2005; 3: 2315-2323","DOI":"10.1111\/j.1538-7836.2005.01554.x"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Sakariassen KS, Orning L, Stormorken H: Role of ADP and thromboxanes in human thrombus formation in ex vivo models. Platelets, 1997; 8: 385-390","DOI":"10.1080\/09537109777069"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Moake JL, Turner NA, Stathopoulos NA, Nolasco L, Hellums JD: Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin. Blood, 1988; 71: 1366-1374","DOI":"10.1182\/blood.V71.5.1366.bloodjournal7151366"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Goto S: Propagation of arterial thrombi: local and remote contributory factors. Arterioscler Thromb Vasc Biol, 2004; 24: 2207-2208","DOI":"10.1161\/01.ATV.0000149144.86175.03"},{"key":"38","unstructured":"38) Gurbel PA, Serebruany VL: Oral platelet IIb\/IIIa inhibitors: from attractive theory to clinical failures. J Thromb Thrombolysis, 2000; 10: 217-220"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/16\/6\/16_2030\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T18:43:45Z","timestamp":1621536225000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/16\/6\/16_2030\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.2030","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009]]}}}